SUB OBJECTIVE 1
Capacity building for the VARG to effectively
engage researchers, scientists and trial networks
STRATEGIC CONTEXT
Advocates rely on current, scientifically sound knowledge to critically analysis and interact with vaccine research. This knowledge enriches and politically situates the local, national, regional and global advocacy positions and informs what engagement and advocacy should look like.
STRATEGIC APPROACH
- Ongoing formalized training and capacity building of advocates in clinical trial research and vaccine development
- Ongoing attendance of and participation in key local, national and global HIV vaccine research forums, network meetings, conferences and dialogue spaces to support informal learning and capacity building
DELIVERABLE SUCCESS
- At least 75% of VARG members complete formalised training and capacity building including annual week-long refresher courses provided by the International Vaccine Institute
- VARG representation at 100% of key research network meetings
- Advocacy feedback reports from 100% of attended network meetings
LEVEL OF ENGAGEMENT
One on one, virtual and group.
SUB OBJECTIVE 2
Capacity building for researchers, scientists and
trial networks to improve partnerships with HIV vaccine advocates
STRATEGIC CONTEXT
Advocates have a wealth of experiences, strategies and approaches that could benefit the work of HIV vaccine researchers, scientists and trial networks.
STRATEGIC APPROACH
Ongoing engagement of researchers, scientists and HIV vaccine clinical trial networks through advocate initiated outreaches in-country as well as at key local, national and global vaccine research forums, network meetings, conferences and dialogue spaces to support informal learning and capacity building.
DELIVERABLE SUCCESS
- Number of face-to-face meetings held with trial leadership teams and PI’s
- VARG representation at 100% of key research network meetings
- Advocacy feedback reports from 100% of attended network meetings and face-to-face interactions
- Online advocacy training modules targeted at scientists and researchers involved in vaccine research
LEVEL OF ENGAGEMENT
One on one, in person and virtual training.
SUB OBJECTIVE 3
Capacity building for journalists to understand
and engage with HIV vaccine research education
STRATEGIC CONTEXT
The media is an essential partner in ensuring that the public receives timely, accurate and evidence based information about HIV vaccine research. They are also in a position to play an important watchdog role for the HIV vaccine research enterprise.
STRATEGIC APPROACH
Media practitioners are interested in representing the diversity of voices involved in and associated with HIV vaccine research. They however need clear information. The VARG recognizes this and facilitates interactions with journalists to ensure the accuracy, validity and scope of HIV vaccine research reporting.
DELIVERABLE SUCCESS
- Number of current HIV Vaccine fact sheets for media practitioners
- Number of face-to-face meetings held with media practitioners and VARG members
- Media partner representation at key research network meetings
- Advocacy feedback reports from 100% of attended network meetings and face-to-face
- interactions
LEVEL OF ENGAGEMENT
One on one, in person and virtual training.